Finland· FI-REL-REL30148
Orikson
A ceftriaxone product containing ceftriaxone sodium, registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 19 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ceftriaxone is registered in 19 of 19 countries.
Countries holding a registration under ATC J01DD04 (ceftriaxone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 11 of them publish a price we can compare per daily dose
Ceftriaxone · ATC J01DD04
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ceftriaxone costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $3.23 in Finland to $33.98 in Switzerland — a ×11 gap.
- Finland: $3.23 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Ceftriaxone · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$33.98
- FR France$13.68
- ES Spain$5.69
- FI Finland$3.23
The record
At a glance
Fimea (Finland)- Active substance
- Ceftriaxone sodium
- Manufacturer
- Orion Corporation Orion Pharma
- Country
- Finland (FI)
- ATC code
- J01DD04
- ATC class
- Ceftriaxone
- Defined daily dose
- 2 g, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
233 interactions on record for ceftriaxone.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ceftriaxone · interactions on record
233 records
- 7 severe
- 20 moderate
- 3 minor
- 203 info
Most severe, free to view
- Calcium gluconateA12AA03severe
- Calcium chlorideA12AA07severe
- Calcium glucoheptonateA12AA10severe
- Calcium chlorideB05XA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ceftriaxone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCEFTRIAXON APTAPHARMAApta Medica Internacional d.o.o., Ljubljana
- SpainCEFTRIAXONA FRESENIUS KABI 1 G, POLVO PARA SOLUCION INYECTABLE INTRAVENOSA EFGFresenius Kabi España, S.A.U.
- PolandBiotraksonZakłady Farmaceutyczne POLPHARMA S.A.
- NorwayCeftriaxon Fresenius Kabi2care4 ApS
- SwedenCeftriaxon Fresenius Kabi 1 g Pulver till injektions-/infusionsvätska, lösningFresenius Kabi AB
- BelgiumCeftriaxon Hameln 1 gHameln Pharma
- IcelandCeftriaxon Fresenius KabiFresenius Kabi AB
- United StatesCeftriaxone SodiumHospira, Inc
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ceftriaxon Aptapharma, Ceftriaxon Ashcure
- Belgium · Ceftriaxon Hameln, Ceftriaxone Fresenius Kabi
- Bulgaria · Медаксон, Цефамед
- Cyprus · Ceftriaxone Sapiens, Ceftrix
- Czechia · Ceftriaxon Aptapharma, Ceftriaxon Kabi
- Germany · Ceftriaxon Cnp, Ceftriaxon Dali Pharma
- Denmark · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Estonia · ceftriaxone Kabi, Ceftriaxone Mip
- Spain · Ceftriaxona Fresenius Kabi, Ceftriaxona Ldp Torlan
- France · Ceftriaxone Almus, Ceftriaxone Arrow
- United Kingdom (Northern Ireland) · Ceftriaxone, Ceftriaxone Aft Pharma Uk
- Greece · Bresec, Bresec(Iv)
- Croatia · Ceftriakson Aptapharma, Ceftriakson Pontus
- Hungary · Ceftriaxon Aptapharma, Ceftriaxon Kabi
- Ireland · Ceftriaxone Hameln, Ceftriaxone Jed Pharma
- Iceland · Ceftriaxon Fresenius Kabi, Ceftriaxon Navamedic
- Italy · Bixon, Caritex
- Lithuania · Ceftriaxone Ashcure, Ceftriaxone Kabi
- Luxembourg · Ceftriaxone Fresenius Kabi, Rocephine
- Latvia · Ceftriaxon Mip, Ceftriaxone Ashcure
- Malta · Ceftriaxone Ashcure, Ceftriaxone Dali Pharma
- Netherlands · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Norway · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Poland · Biotrakson, Ceftriaxon Aptapharma
- Portugal · Betasporina, Betasporina Im
- Romania · Cefort, Ceftriaxonă Aptapharma
- Sweden · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
- Slovenia · Ceftriakson Aptapharma, Ceftriakson Pontus
- Slovakia · Ceftriaxón Aptapharma, Ceftriaxon Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e38bad14-1666-4896-b23c-5bfb1980a0c2 GET /v1/drugs/e38bad14-1666-4896-b23c-5bfb1980a0c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "injektio/infuusiokuiva-aine, liuosta varten ",
"route": null,
"ddd_unit": "g",
"strength": "1 g",
"atc_label": "keftriaksoni",
"ma_number": "24504",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL30148",
"authorised_at": "2009-05-11"
}See everything about ceftriaxone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.